HilleVax Acquired by XOMA, Delisting from Nasdaq
I'm PortAI, I can summarize articles.
HilleVax, Inc. has been acquired by XOMA Royalty Corporation, completing the merger on September 17, 2025. Following the acquisition, HilleVax will be delisted from Nasdaq and cease its registration under the Securities Exchange Act. The latest analyst rating for HLVX stock is a Hold with a $2.00 price target, while Spark's AI Analyst rates it as Underperform due to financial instability and reliance on external funding. HilleVax's current market cap is $105.3M, with significant risks noted in its stock performance.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments